Category Archives: Health Care News

Gilenya Multiple Sclerosis Drug: What Are Its Side Effects?

Published by:

What are the side effects of the newly approved anti multiple sclerosis drug, Gilenya? Read the write-up below.

*****
An oral pill which treats the underlying causes of multiple sclerosis or MS has gained the approval of the US Food and Drugs Administration.

Gilenya, from Swiss drugmaker Novartis, gained the unanimous endorsement of the FDA which voted 25-0 to approve the drug.

Continue reading









Quality Care in U.S. Hospitals: Good, Bad, or Improving?

Published by:

Quality Care in U.S. Hospitals: Good, Bad, or Improving? Quality of care in hospitals and other health centers across the United States has shown improvements over the past eight years, a national health care accrediting organization revealed.

According to a report from Businessweek, The Joint Commission found that there is a big improvement on US hospitals in caring for patients with heart attack, pneumonia, surgery and children’s asthma.

Continue reading









Krystexxa Anti-Gout Drug Approved by FDA

Published by:

Krystexxa Anti-Gout Drug Approved by FDA. The U.S Food and Drug Administration has approved a drug to cure gout among adults who cannot tolerate or respond to existing treatments.

The US FDA approved Krystexxa to treat the painful condition which is characterized by swelling, redness, heat, pain and stiffness in the joints. Kyystexxa lowers uric acid levels by metabolizing it into a harmless chemical that is excreted in the urine.

“Since one out of every four patients in the clinical trials experienced a severe allergic reaction when receiving an infusion of Krystexxa, health care providers should dispense a corticosteroid and an antihistamine to their patients beforehand to minimize the risk of such a reaction. Other reactions during the clinical trials included gout flare, nausea, injection site bruising, irritation of the nasal passages, constipation, chest pain and vomiting”, the FDA news release says.

Continue reading